Completed OBSERVATIONAL NCT00450281

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men

Sponsor: National Cancer Institute (NCI)

Interventions chromogenic in situ hybridization fluorescent antibody technique gene expression analysis immunohistochemistry staining method laboratory biomarker analysis matrix-assisted laser desorption/ionization time of flight mass spectrometry mutation analysis polymerase chain reaction polymorphism analysis study of high risk factors study of socioeconomic and demographic variables

Updated 8 times since 2017 Last updated: Oct 23, 2015 Started: Oct 31, 2005 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00450281, this observational or N/A phase trial focuses on Lung Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 8 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — May 2023 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
SWOG Cancer Research Network

Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adrian, United States , Akron, United States , Allentown, United States , Alton, United States , American Fork, United States , Anchorage, United States , Anderson, United States , Ann Arbor, United States , Anthony, United States , Antioch, United States and 258 more locations